Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease
- PMID: 34851977
- PMCID: PMC8635374
- DOI: 10.1371/journal.pone.0259935
Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease
Abstract
Objective: To prospectively evaluate nocturnal sleep problems and excessive daytime sleepiness (EDS) in Parkinson's disease (PD) patients, and analyze the influence of motor symptoms, treatment, and sex differences on sleep problems in PD.
Methods: Sleep disturbances of 103 PD patients were assessed with Parkinson's Disease Sleep Scale (PDSS) and the Epworth Sleepiness Scale (ESS). Student's t-test for related samples, one-way ANOVA with Tukey's HSD post hoc test were used to assess group differences. Bivariate correlations and mixed-effects linear regression models were used to analyze the association between clinical aspects and sleep disturbances over time.
Results: At baseline, 48.5% of PD patients presented nocturnal problems and 40% of patients presented EDS. The PDSS and ESS total score slightly improve over time. Nocturnal problems were associated with age and motor impartment, explaining the 51% of the variance of the PDSS model. Males presented less nocturnal disturbances and more EDS than females. Higher motor impairment and combined treatment (L-dopa and agonist) were related to more EDS, while disease duration and L-dopa in monotherapy were related to lower scores, explaining the 59% of the model.
Conclusions: Sleep disturbances changed over time and age, diseases duration, motor impairment, treatment and sex were associated with nocturnal sleep problems and EDS. Agonist treatment alone or in combination with L-dopa might predict worse daytime sleepiness, while L-dopa in monotherapy is related to lower EDS, which significantly affects the quality of life of PD patients.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Association between Sleep Disturbances and Daytime Somnolence in Parkinson's Disease.Eur Neurol. 2018;80(5-6):268-276. doi: 10.1159/000496937. Epub 2019 Feb 7. Eur Neurol. 2018. PMID: 30731467
-
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson's disease patients.J Neurol. 2024 Jun;271(6):3625-3630. doi: 10.1007/s00415-024-12351-y. Epub 2024 Apr 12. J Neurol. 2024. PMID: 38607429
-
Sleep disturbances in Taiwanese patients with Parkinson's disease.Brain Behav. 2017 Sep 21;7(10):e00806. doi: 10.1002/brb3.806. eCollection 2017 Oct. Brain Behav. 2017. PMID: 29075566 Free PMC article.
-
Approaching disturbed sleep in late Parkinson's Disease: first step toward a proposal for a revised UPDRS.Parkinsonism Relat Disord. 2001 Oct;8(2):123-31. doi: 10.1016/s1353-8020(01)00026-8. Parkinsonism Relat Disord. 2001. PMID: 11489677 Review.
-
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease.Neurology. 2004 Oct 26;63(8 Suppl 3):S35-8. doi: 10.1212/wnl.63.8_suppl_3.s35. Neurology. 2004. PMID: 15505142 Review.
Cited by
-
Longitudinal Studies of Sleep Disturbances in Parkinson's Disease.Curr Neurol Neurosci Rep. 2022 Oct;22(10):635-655. doi: 10.1007/s11910-022-01223-5. Epub 2022 Aug 26. Curr Neurol Neurosci Rep. 2022. PMID: 36018498 Free PMC article. Review.
-
Epworth sleepiness scale is associated with increased striatal dopamine uptake in Parkinson's disease: a cross-sectional study.Neurol Sci. 2024 Jan;45(1):149-154. doi: 10.1007/s10072-023-06974-8. Epub 2023 Jul 28. Neurol Sci. 2024. PMID: 37505301
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical